MiMedx Group, Inc. (MDXG)
3.91
-0.02
(-0.51%)
USD |
NASDAQ |
Oct 23, 16:00
3.905
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Price to Book Value : 2.638 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.638 |
| October 22, 2026 | 2.651 |
| October 21, 2026 | 2.523 |
| October 20, 2026 | 2.854 |
| October 19, 2026 | 2.955 |
| October 16, 2026 | 2.989 |
| October 15, 2026 | 3.157 |
| October 14, 2026 | 3.171 |
| October 13, 2026 | 3.164 |
| October 12, 2026 | 3.258 |
| October 09, 2026 | 3.151 |
| October 08, 2026 | 3.117 |
| October 07, 2026 | 3.110 |
| October 06, 2026 | 3.117 |
| October 05, 2026 | 3.070 |
| October 02, 2026 | 3.097 |
| October 01, 2026 | 3.130 |
| September 30, 2026 | 3.144 |
| September 29, 2026 | 3.151 |
| September 28, 2026 | 3.157 |
| September 25, 2026 | 3.151 |
| September 24, 2026 | 3.178 |
| September 23, 2026 | 3.218 |
| September 22, 2026 | 3.326 |
| September 21, 2026 | 3.245 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.218 |
| September 17, 2026 | 3.164 |
| September 16, 2026 | 3.191 |
| September 15, 2026 | 3.184 |
| September 14, 2026 | 3.130 |
| September 11, 2026 | 3.083 |
| September 10, 2026 | 3.103 |
| September 09, 2026 | 3.157 |
| September 08, 2026 | 3.151 |
| September 04, 2026 | 3.083 |
| September 03, 2026 | 2.989 |
| September 02, 2026 | 3.070 |
| September 01, 2026 | 3.049 |
| August 31, 2026 | 3.063 |
| August 28, 2026 | 3.036 |
| August 27, 2026 | 3.043 |
| August 26, 2026 | 2.982 |
| August 25, 2026 | 2.928 |
| August 24, 2026 | 2.881 |
| August 21, 2026 | 2.921 |
| August 20, 2026 | 2.901 |
| August 19, 2026 | 3.002 |
| August 18, 2026 | 2.928 |
| August 17, 2026 | 2.827 |
| August 14, 2026 | 2.881 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.088 |
| Perspective Therapeutics, Inc. | 0.5671 |
| ABVC BioPharma, Inc. | 2.605 |
| Enovis Corp. | 0.823 |
| Edwards Lifesciences Corp. | 4.837 |
Price to Book Value Related Metrics
| PE Ratio | 98.99 |
| PS Ratio | 1.641 |
| Price to Free Cash Flow | 13.77 |
| Price | 3.91 |
| Earnings Yield | 1.01% |
| Market Cap | 569.78M |
| Operating PE Ratio | 66.58 |
| Normalized PE Ratio | 99.24 |